Detection of early stages of Alzheimer's disease based on MEG activity with a randomized convolutional neural network

Enhancing early Alzheimer's disease classification accuracy through the fusion of sMRI and rsMEG data: a deep learning approach

Objective

Early detection and prediction of Alzheimer's Disease are paramount for elucidating neurodegenerative processes and enhancing cognitive resilience. Structural Magnetic Resonance Imaging (sMRI) provides insights into brain morphology, while resting-state Magnetoencephalography (rsMEG) elucidates functional aspects. However, inherent disparities between these multimodal neuroimaging modalities pose challenges to the effective integration of multimodal features.

Approach

To address these challenges, we propose a deep learning-based multimodal classification framework for Alzheimer's disease, which harnesses the fusion of pivotal features from sMRI and rsMEG to augment classification precision. Utilizing the BioFIND dataset, classification trials were conducted on 163 Mild Cognitive Impairment cases and 144 cognitively Healthy Controls.

Results

The study findings demonstrate that the InterFusion method, combining sMRI and rsMEG data, achieved a classification accuracy of 0.827. This accuracy significantly surpassed the accuracies obtained by rsMEG only at 0.710 and sMRI only at 0.749. Moreover, the evaluation of different fusion techniques revealed that InterFusion outperformed both EarlyFusion with an accuracy of 0.756 and LateFusion with an accuracy of 0.801. Additionally, the study delved deeper into the role of different frequency band features of rsMEG in fusion by analyzing six frequency bands, thus expanding the diagnostic scope.

Discussion

These results highlight the value of integrating resting-state rsMEG and sMRI data in the early diagnosis of Alzheimer's disease, demonstrating significant potential in the field of neuroscience diagnostics.

Insights into AlphaFold's breakthrough in neurodegenerative diseases

Neurodegenerative diseases (ND) are disorders of the central nervous system (CNS) characterized by impairment in neurons' functions, and complete loss, leading to memory loss, and difficulty in learning, language, and movement processes. The most common among these NDs are Alzheimer's disease (AD) and Parkinson's disease (PD), although several other disorders also exist. These are frontotemporal dementia (FTD), amyotrophic lateral syndrome (ALS), Huntington's disease (HD), and others; the major pathological hallmark of NDs is the proteinopathies, either of amyloid-β (Aβ), tauopathies, or synucleinopathies. Aggregation of proteins that do not undergo normal configuration, either due to mutations or through some disturbance in cellular pathway contributes to the diseases. Artificial Intelligence (AI) and deep learning (DL) have proven to be successful in the diagnosis and treatment of various congenital diseases. DL approaches like AlphaFold (AF) are a major leap towards success in CNS disorders. This 3D protein geometry modeling algorithm developed by DeepMind has the potential to revolutionize biology. AF has the potential to predict 3D-protein confirmation at an accuracy level comparable to experimentally predicted one, with the additional advantage of precisely estimating protein interactions. This breakthrough will be beneficial to identify diseases' advancement and the disturbance of signaling pathways stimulating impaired functions of proteins. Though AlphaFold has solved a major problem in structural biology, it cannot predict membrane proteins-a beneficial approach for drug designing.

Deep Multi-Branch CNN Architecture for Early Alzheimer's Detection from Brain MRIs

Alzheimer's disease (AD) is a neurodegenerative disease that can cause dementia and result in a severe reduction in brain function, inhibiting simple tasks, especially if no preventative care is taken. Over 1 in 9 Americans suffer from AD-induced dementia, and unpaid care for people with AD-related dementia is valued at USD 271.6 billion. Hence, various approaches have been developed for early AD diagnosis to prevent its further progression. In this paper, we first review other approaches that could be used for the early detection of AD. We then give an overview of our dataset and propose a deep convolutional neural network (CNN) architecture consisting of 7,866,819 parameters. This model comprises three different convolutional branches, each having a different length. Each branch is comprised of different kernel sizes. This model can predict whether a patient is non-demented, mild-demented, or moderately demented with a 99.05% three-class accuracy. In summary, the deep CNN model demonstrated exceptional accuracy in the early diagnosis of AD, offering a significant advancement in the field and the potential to improve patient care.

Multimodal multitask learning for predicting MCI to AD conversion using stacked polynomial attention network and adaptive exponential decay

Early identification and treatment of moderate cognitive impairment (MCI) can halt or postpone Alzheimer's disease (AD) and preserve brain function. For prompt diagnosis and AD reversal, precise prediction in the early and late phases of MCI is essential. This research investigates multimodal framework-based multitask learning in the following situations: (1) Differentiating early mild cognitive impairment (eMCI) from late MCI and (2) predicting when an MCI patient would acquire AD. Clinical data and two radiomics features on three brain areas deduced from magnetic resonance imaging were investigated (MRI). We proposed an attention-based module, Stack Polynomial Attention Network (SPAN), to firmly encode clinical and radiomics data input characteristics for successful representation from a small dataset. To improve multimodal data learning, we computed a potent factor using adaptive exponential decay (AED). We used experiments from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort study, which included 249 eMCI and 427 lMCI participants at baseline visits. The proposed multimodal strategy yielded the best c-index score in time prediction of MCI to AD conversion (0.85) and the best accuracy in MCI-stage categorization ([Formula: see text]). Moreover, our performance was equivalent to that of contemporary research.

Detecting mild cognitive impairment and dementia in older adults using naturalistic driving data and interaction-based classification from influence score

Several recent studies indicate that atypical changes in driving behaviors appear to be early signs of mild cognitive impairment (MCI) and dementia. These studies, however, are limited by small sample sizes and short follow-up duration. This study aims to develop an interaction-based classification method building on a statistic named Influence Score (i.e., I-score) for prediction of MCI and dementia using naturalistic driving data collected from the Longitudinal Research on Aging Drivers (LongROAD) project. Naturalistic driving trajectories were collected through in-vehicle recording devices for up to 44 months from 2977 participants who were cognitively intact at the time of enrollment. These data were further processed and aggregated to generate 31 time-series driving variables. Because of high dimensional time-series features for driving variables, we used I-score for variable selection. I-score is a measure to evaluate variables' ability to predict and is proven to be effective in differentiating between noisy and predictive variables in big data. It is introduced here to select influential variable modules or groups that account for compound interactions among explanatory variables. It is explainable regarding to what extent variables and their interactions contribute to the predictiveness of a classifier. In addition, I-score boosts the performance of classifiers over imbalanced datasets due to its association with the F1 score. Using predictive variables selected by I-score, interaction-based residual blocks are constructed over top I-score modules to generate predictors and ensemble learning aggregates these predictors to boost the prediction of the overall classifier. Experiments using naturalistic driving data show that our proposed classification method achieves the best accuracy (96%) for predicting MCI and dementia, followed by random forest (93%) and logistic regression (88%). In terms of F1 score and AUC, our proposed classifier achieves 98% and 87%, respectively, followed by random forest (with an F1 score of 96% and an AUC of 79%) and logistic regression (with an F1 score of 92% and an AUC of 77%). The results indicate that incorporating I-score into machine learning algorithms could considerably improve the model performance for predicting MCI and dementia in older drivers. We also performed the feature importance analysis and found that the right to left turn ratio and the number of hard braking events are the most important driving variables to predict MCI and dementia.

Development and Validation of Embedded Device for Electrocardiogram Arrhythmia Empowered with Transfer Learning

With the emergence of the Internet of Things (IoT), investigation of different diseases in healthcare improved, and cloud computing helped to centralize the data and to access patient records throughout the world. In this way, the electrocardiogram (ECG) is used to diagnose heart diseases or abnormalities. The machine learning techniques have been used previously but are feature-based and not as accurate as transfer learning; the proposed development and validation of embedded device prove ECG arrhythmia by using the transfer learning (DVEEA-TL) model. This model is the combination of hardware, software, and two datasets that are augmented and fused and further finds the accuracy results in high proportion as compared to the previous work and research. In the proposed model, a new dataset is made by the combination of the Kaggle dataset and the other, which is made by taking the real-time healthy and unhealthy datasets, and later, the AlexNet transfer learning approach is applied to get a more accurate reading in terms of ECG signals. In this proposed research, the DVEEA-TL model diagnoses the heart abnormality in respect of accuracy during the training and validation stages as 99.9% and 99.8%, respectively, which is the best and more reliable approach as compared to the previous research in this field.

Deep Ensemble Learning for the Automatic Detection of Pneumoconiosis in Coal Worker’s Chest X-ray Radiography

Globally, coal remains one of the natural resources that provide power to the world. Thousands of people are involved in coal collection, processing, and transportation. Particulate coal dust is produced during these processes, which can crush the lung structure of workers and cause pneumoconiosis. There is no automated system for detecting and monitoring diseases in coal miners, except for specialist radiologists. This paper proposes ensemble learning techniques for detecting pneumoconiosis disease in chest X-ray radiographs (CXRs) using multiple deep learning models. Three ensemble learning techniques (simple averaging, multi-weighted averaging, and majority voting (MVOT)) were proposed to investigate performances using randomised cross-folds and leave-one-out cross-validations datasets. Five statistical measurements were used to compare the outcomes of the three investigations on the proposed integrated approach with state-of-the-art approaches from the literature for the same dataset. In the second investigation, the statistical combination was marginally enhanced in the ensemble of multi-weighted averaging on a robust model, CheXNet. However, in the third investigation, the same model elevated accuracies from 87.80 to 90.2%. The investigated results helped us identify a robust deep learning model and ensemble framework that outperformed others, achieving an accuracy of 91.50% in the automated detection of pneumoconiosis.

ECG Classification for Detecting ECG Arrhythmia Empowered with Deep Learning Approaches

According to the World Health Organization (WHO) report, heart disease is spreading throughout the world very rapidly and the situation is becoming alarming in people aged 40 or above (Xu, 2020). Different methods and procedures are adopted to detect and diagnose heart abnormalities. Data scientists are working on finding the different methods with the required accuracy (Strodthoff et al., 2021). Electrocardiogram (ECG) is the procedure to find the heart condition in the waveform. For ages, the machine learning techniques, which are feature based, played a vital role in the medical sciences and centralized the data in cloud computing and having access throughout the world. Furthermore, deep learning or transfer learning widens the vision and introduces different transfer learning methods to ensure accuracy and time management to detect the ECG in a better way in comparison to the previous and machine learning methods. Hence, it is said that transfer learning has turned world research into more appropriate and innovative research. Here, the proposed comparison and accuracy analysis of different transfer learning methods by using ECG classification for detecting ECG Arrhythmia (CAA-TL). The CAA-TL model has the multiclassification of the ECG dataset, which has been taken from Kaggle. Some of the healthy and unhealthy datasets have been taken in real-time, augmented, and fused with the Kaggle dataset, i.e., Massachusetts Institute of Technology-Beth Israel Hospital (MIT-BIH dataset). The CAA-TL worked on the accuracy of heart problem detection by using different methods like ResNet50, AlexNet, and SqueezeNet. All three deep learning methods showed remarkable accuracy, which is improved from the previous research. The comparison of different deep learning approaches with respect to layers widens the research and gives the more clarity and accuracy and at the same time finds it time-consuming while working with multiclassification with massive dataset of ECG. The implementation of the proposed method showed an accuracy of 98.8%, 90.08%, and 91% for AlexNet, SqueezeNet, and ResNet50, respectively.

An Efficient Multi-Scale Convolutional Neural Network Based Multi-Class Brain MRI Classification for SaMD

A brain tumor is the growth of abnormal cells in certain brain tissues with a high mortality rate; therefore, it requires high precision in diagnosis, as a minor human judgment can eventually cause severe consequences. Magnetic Resonance Image (MRI) serves as a non-invasive tool to detect the presence of a tumor. However, Rician noise is inevitably instilled during the image acquisition process, which leads to poor observation and interferes with the treatment. Computer-Aided Diagnosis (CAD) systems can perform early diagnosis of the disease, potentially increasing the chances of survival, and lessening the need for an expert to analyze the MRIs. Convolutional Neural Networks (CNN) have proven to be very effective in tumor detection in brain MRIs. There have been multiple studies dedicated to brain tumor classification; however, these techniques lack the evaluation of the impact of the Rician noise on state-of-the-art deep learning techniques and the consideration of the scaling impact on the performance of the deep learning as the size and location of tumors vary from image to image with irregular shape and boundaries. Moreover, transfer learning-based pre-trained models such as AlexNet and ResNet have been used for brain tumor detection. However, these architectures have many trainable parameters and hence have a high computational cost. This study proposes a two-fold solution: (a) Multi-Scale CNN (MSCNN) architecture to develop a robust classification model for brain tumor diagnosis, and (b) minimizing the impact of Rician noise on the performance of the MSCNN. The proposed model is a multi-class classification solution that classifies MRIs into glioma, meningioma, pituitary, and non-tumor. The core objective is to develop a robust model for enhancing the performance of the existing tumor detection systems in terms of accuracy and efficiency. Furthermore, MRIs are denoised using a Fuzzy Similarity-based Non-Local Means (FSNLM) filter to improve the classification results. Different evaluation metrics are employed, such as accuracy, precision, recall, specificity, and F1-score, to evaluate and compare the performance of the proposed multi-scale CNN and other state-of-the-art techniques, such as AlexNet and ResNet. In addition, trainable and non-trainable parameters of the proposed model and the existing techniques are also compared to evaluate the computational efficiency. The experimental results show that the proposed multi-scale CNN model outperforms AlexNet and ResNet in terms of accuracy and efficiency at a lower computational cost. Based on experimental results, it is found that our proposed MCNN2 achieved accuracy and F1-score of 91.2% and 91%, respectively, which is significantly higher than the existing AlexNet and ResNet techniques. Moreover, our findings suggest that the proposed model is more effective and efficient in facilitating clinical research and practice for MRI classification.

Deep Learning-Based Diagnosis of Alzheimer's Disease

Alzheimer's disease (AD), the most familiar type of dementia, is a severe concern in modern healthcare. Around 5.5 million people aged 65 and above have AD, and it is the sixth leading cause of mortality in the US. AD is an irreversible, degenerative brain disorder characterized by a loss of cognitive function and has no proven cure. Deep learning techniques have gained popularity in recent years, particularly in the domains of natural language processing and computer vision. Since 2014, these techniques have begun to achieve substantial consideration in AD diagnosis research, and the number of papers published in this arena is rising drastically. Deep learning techniques have been reported to be more accurate for AD diagnosis in comparison to conventional machine learning models. Motivated to explore the potential of deep learning in AD diagnosis, this study reviews the current state-of-the-art in AD diagnosis using deep learning. We summarize the most recent trends and findings using a thorough literature review. The study also explores the different biomarkers and datasets for AD diagnosis. Even though deep learning has shown promise in AD diagnosis, there are still several challenges that need to be addressed.

An effective convolutional neural network-based stacked long short-term memory approach for automated Alzheimer’s disease prediction

In today’s world, Alzheimer’s Disease (AD) is one of the prevalent neurological diseases where early disease prediction can significantly enhance the compatibility of patient treatment. Nevertheless, accurate diagnosis and optimal feature selection play a vital challenge in AD detection. Most of the existing diagnosis systems failed to attain superior prediction accuracy and precision rate. In order to mitigate these constraints, a new efficient Convolutional Neural Network-based Stacked Long Short-Term Memory (CNN-SLSTM) methodology has been proposed in this paper. The key objective of the proposed model is to examine the brain’s condition and evaluate the changes that occur throughout the interracial period. The proposed model includes multi-feature learning and categorization in which the raw Electroencephalography (EEG) data will be passed via the feature extractor to decrease the computing complexity and execution time. Afterward, the SLSTM network is constructed with completely linked layer and activation layers to record the temporal relationship between features and the next stage of AD. The proposed CNN-SLSTM model can be trained using real-time EEG sensor data. The performance results clearly apparent that the proposed model can efficiently predict the AD with superior accuracy of 98.67% and precision of 98.86% when compared with existing state-of-the-art techniques.

Multi-attack and multi-classification intrusion detection for vehicle-mounted networks based on mosaic-coded convolutional neural network

With the development of Internet of vehicles, the information exchange between vehicles and the outside world results in a higher risk of external network attacks to the vehicles. The attack modes to the most widely used vehicle-mounted CAN bus are complex and diverse, but most of the intrusion detection approaches proposed by now can only detect one type of attack at a time. Aiming at detecting multi-types of attacks using a single model, we proposed a detection method based on the Mosaic-coded convolution neural network for intrusions containing various combinations of attacks with multi-classification capability. A Mosaic-like two-dimensional data grid was created from the one-dimensional CAN ID for the CNN to effectively extract the data features and maintain the time connections between the CAN IDs. Four types of attacks and all possible combinations of them were used to train and test our model. The autoencoder was also used to reduce the dimensionality of the data so as to cut down the model's complexity. Experimental results showed that the proposed method was effective in detecting all types of attack combinations with high and stable multi-classification ability.

Fully automated discrimination of Alzheimer's disease using resting-state electroencephalography signals

Background

The Alzheimer's disease (AD) population increases worldwide, placing a heavy burden on the economy and society. Presently, there is no cure for AD. Developing a convenient method of screening for AD and mild cognitive impairment (MCI) could enable early intervention, thus slowing down the progress of the disease and enabling better overall disease management.

Methods

In the current study, resting-state electroencephalography (EEG) data were acquired from 113 normal cognition (NC) subjects, 116 amnestic MCI patients, and 72 probable AD patients. After preprocessing by an automatic algorithm, features including spectral power, complexity, and functional connectivity were extracted, and machine-learning classifiers were built to differentiate among the 3 groups. The classification performance was evaluated from multiple perspectives, including accuracy, specificity, sensitivity, area under the curve (AUC) with 95% confidence intervals, and compared to the empirical chance level by permutation tests.

Results

The analysis of variance results (P<0.05 with false discovery rate correction) confirmed the tendency to slow brain activity, reduced complexity, and connectivity with AD progress. By combining the features, the ability of the machine-learning classifiers, especially the ensemble trees, to differentiate among the 3 groups, was significantly better than that of the empirical chance level of the permutation test. The AUC of the classifier with the best performance was 80.08% for AD vs. NC, 70.82% for AD vs. MCI, and 63.95% for MCI vs. NC.

Conclusions

The current study presented a fully automatic procedure that could significantly distinguish NC, MCI, and AD subjects via resting-state EEG signals. The study was based on a large data set with evidence-based medical diagnosis and provided further evidence that resting-state EEG data could assist in the discrimination of AD patients.

The Road to Personalized Medicine in Alzheimer’s Disease: The Use of Artificial Intelligence

Dementia remains an extremely prevalent syndrome among older people and represents a major cause of disability and dependency. Alzheimer’s disease (AD) accounts for the majority of dementia cases and stands as the most common neurodegenerative disease. Since age is the major risk factor for AD, the increase in lifespan not only represents a rise in the prevalence but also adds complexity to the diagnosis. Moreover, the lack of disease-modifying therapies highlights another constraint. A shift from a curative to a preventive approach is imminent and we are moving towards the application of personalized medicine where we can shape the best clinical intervention for an individual patient at a given point. This new step in medicine requires the most recent tools and analysis of enormous amounts of data where the application of artificial intelligence (AI) plays a critical role on the depiction of disease–patient dynamics, crucial in reaching early/optimal diagnosis, monitoring and intervention. Predictive models and algorithms are the key elements in this innovative field. In this review, we present an overview of relevant topics regarding the application of AI in AD, detailing the algorithms and their applications in the fields of drug discovery, and biomarkers.

Deep neural network for the determination of transformed foci in Bhas 42 cell transformation assay

Bhas 42 cell transformation assay (CTA) has been used to estimate the carcinogenic potential of chemicals by exposing Bhas 42 cells to carcinogenic stimuli to form colonies, referred to as transformed foci, on the confluent monolayer. Transformed foci are classified and quantified by trained experts using morphological criteria. Although the assay has been certified by international validation studies and issued as a guidance document by OECD, this classification process is laborious, time consuming, and subjective. We propose using deep neural network to classify foci more rapidly and objectively. To obtain datasets, Bhas 42 CTA was conducted with a potent tumor promotor, 12-O-tetradecanoylphorbol-13-acetate, and focus images were classified by experts (1405 images in total). The labeled focus images were augmented with random image processing and used to train a convolutional neural network (CNN). The trained CNN exhibited an area under the curve score of 0.95 on a test dataset significantly outperforming conventional classifiers by beginners of focus judgment. The generalization performance of unknown chemicals was assessed by applying CNN to other tumor promotors exhibiting an area under the curve score of 0.87. The CNN-based approach could support the assay for carcinogenicity as a fundamental tool in focus scoring.

The Feasibility of Differentiating Lewy Body Dementia and Alzheimer's Disease by Deep Learning Using ECD SPECT Images

The correct differential diagnosis of dementia has an important impact on patient treatment and follow-up care strategies. Tc-99m-ECD SPECT imaging, which is low cost and accessible in general clinics, is used to identify the two common types of dementia, Alzheimer's disease (AD) and Lewy body dementia (LBD). Two-stage transfer learning technology and reducing model complexity based on the ResNet-50 model were performed using the ImageNet data set and ADNI database. To improve training accuracy, the three-dimensional image was reorganized into three sets of two-dimensional images for data augmentation and ensemble learning, then the performance of various deep learning models for Tc-99m-ECD SPECT images to distinguish AD/normal cognition (NC), LBD/NC, and AD/LBD were investigated. In the AD/NC, LBD/NC, and AD/LBD tasks, the AUC values were around 0.94, 0.95, and 0.74, regardless of training models, with an accuracy of 90%, 87%, and 71%, and F1 scores of 89%, 86%, and 76% in the best cases. The use of transfer learning and a modified model resulted in better prediction results, increasing the accuracy by 32% for AD/NC. The proposed method is practical and could rapidly utilize a deep learning model to automatically extract image features based on a small number of SPECT brain perfusion images in general clinics to objectively distinguish AD and LBD.

Multi-Class brain normality and abnormality diagnosis using modified Faster R-CNN

BACKGROUND AND OBJECTIVE

The detection and analysis of brain disorders through medical imaging techniques are extremely important to get treatment on time and sustain a healthy lifestyle. Disorders cause permanent brain damage and alleviate the lifespan. Moreover, the classification of large volumes of medical image data manually by medicine experts is tiring, time-consuming, and prone to errors. This study aims to diagnose brain normality and abnormalities using a novel ResNet50 modified Faster Regions with Convolutional Neural Network(R-CNN) model. The classification task is performed into multiple classes which are hemorrhage, hydrocephalus, and normal. The proposed model both determines the borders of the normal/abnormal parts and classifies them with the highest accuracy.

METHODS

To provide a comprehensive performance analysis in the classification problem, Machine Learning(ML) and Deep Learning(DL) techniques were discussed. Artificial Neural Network(ANN), AdaBoost(AB), Decision Tree(DT), Logistic Regression(LR), Naive Bayes(NB), Random Forest(RF), and Support Vector Machine(SVM) were used as ML models. Besides, various Convolutional Neural Network(CNN) models and proposed ResNet50 modified Faster R-CNN model were used as DL models. Methods were validated using a novel brain dataset that contains both normal and abnormal images.

RESULTS

Based on results, LR obtained the highest result among ML methods and DenseNet201 obtained the highest results among CNN models with the accuracy of 84.80% and 85.68% for the classification task, respectively. Besides, the accuracy obtained by the proposed model is 99.75%.

CONCLUSIONS

Experimental results demonstrate that the proposed model has yielded better performance for detection and classification tasks. This artificial intelligence(AI) framework can be utilized as a computer-aided medical decision support system for medical experts.

Categorizing objects from MEG signals using EEGNet

Magnetoencephalography (MEG) signals have demonstrated their practical application to reading human minds. Current neural decoding studies have made great progress to build subject-wise decoding models to extract and discriminate the temporal/spatial features in neural signals. In this paper, we used a compact convolutional neural network-EEGNet-to build a common decoder across subjects, which deciphered the categories of objects (faces, tools, animals, and scenes) from MEG data. This study investigated the influence of the spatiotemporal structure of MEG on EEGNet's classification performance. Furthermore, the EEGNet replaced its convolution layers with two sets of parallel convolution structures to extract the spatial and temporal features simultaneously. Our results showed that the organization of MEG data fed into the EEGNet has an effect on EEGNet classification accuracy, and the parallel convolution structures in EEGNet are beneficial to extracting and fusing spatial and temporal MEG features. The classification accuracy demonstrated that the EEGNet succeeds in building the common decoder model across subjects, and outperforms several state-of-the-art feature fusing methods.

DeepFeature: feature selection in nonimage data using convolutional neural network

Artificial intelligence methods offer exciting new capabilities for the discovery of biological mechanisms from raw data because they are able to detect vastly more complex patterns of association that cannot be captured by classical statistical tests. Among these methods, deep neural networks are currently among the most advanced approaches and, in particular, convolutional neural networks (CNNs) have been shown to perform excellently for a variety of difficult tasks. Despite that applications of this type of networks to high-dimensional omics data and, most importantly, meaningful interpretation of the results returned from such models in a biomedical context remains an open problem. Here we present, an approach applying a CNN to nonimage data for feature selection. Our pipeline, DeepFeature, can both successfully transform omics data into a form that is optimal for fitting a CNN model and can also return sets of the most important genes used internally for computing predictions. Within the framework, the Snowfall compression algorithm is introduced to enable more elements in the fixed pixel framework, and region accumulation and element decoder is developed to find elements or genes from the class activation maps. In comparative tests for cancer type prediction task, DeepFeature simultaneously achieved superior predictive performance and better ability to discover key pathways and biological processes meaningful for this context. Capabilities offered by the proposed framework can enable the effective use of powerful deep learning methods to facilitate the discovery of causal mechanisms in high-dimensional biomedical data.

Deep-MEG: spatiotemporal CNN features and multiband ensemble classification for predicting the early signs of Alzheimer’s disease with magnetoencephalography

In this paper, we present the novel Deep-MEG approach in which image-based representations of magnetoencephalography (MEG) data are combined with ensemble classifiers based on deep convolutional neural networks. For the scope of predicting the early signs of Alzheimer’s disease (AD), functional connectivity (FC) measures between the brain bio-magnetic signals originated from spatially separated brain regions are used as MEG data representations for the analysis. After stacking the FC indicators relative to different frequency bands into multiple images, a deep transfer learning model is used to extract different sets of deep features and to derive improved classification ensembles. The proposed Deep-MEG architectures were tested on a set of resting-state MEG recordings and their corresponding magnetic resonance imaging scans, from a longitudinal study involving 87 subjects. Accuracy values of 89% and 87% were obtained, respectively, for the early prediction of AD conversion in a sample of 54 mild cognitive impairment subjects and in a sample of 87 subjects, including 33 healthy controls. These results indicate that the proposed Deep-MEG approach is a powerful tool for detecting early alterations in the spectral–temporal connectivity profiles and in their spatial relationships.

Magnetoencephalography: physics, techniques, and applications in the basic and clinical neurosciences

Magnetoencephalography (MEG) is a technique used to measure the magnetic fields generated from neuronal activity in the brain. MEG has a high temporal resolution on the order of milliseconds and provides a more direct measure of brain activity when compared with hemodynamic-based neuroimaging methods such as magnetic resonance imaging and positron emission tomography. The current review focuses on basic features of MEG such as the instrumentation and the physics that are integral to the signals that can be measured, and the principles of source localization techniques, particularly the physics of beamforming and the techniques that are used to localize the signal of interest. In addition, we review several metrics that can be used to assess functional coupling in MEG and describe the advantages and disadvantages of each approach. Lastly, we discuss the current and future applications of MEG.

Colorectal Cancer Prediction Based on Weighted Gene Co-Expression Network Analysis and Variational Auto-Encoder

An effective feature extraction method is key to improving the accuracy of a prediction model. From the Gene Expression Omnibus (GEO) database, which includes 13,487 genes, we obtained microarray gene expression data for 238 samples from colorectal cancer (CRC) samples and normal samples. Twelve gene modules were obtained by weighted gene co-expression network analysis (WGCNA) on 173 samples. By calculating the Pearson correlation coefficient (PCC) between the characteristic genes of each module and colorectal cancer, we obtained a key module that was highly correlated with CRC. We screened hub genes from the key module by considering module membership, gene significance, and intramodular connectivity. We selected 10 hub genes as a type of feature for the classifier. We used the variational autoencoder (VAE) for 1159 genes with significantly different expressions and mapped the data into a 10-dimensional representation, as another type of feature for the cancer classifier. The two types of features were applied to the support vector machines (SVM) classifier for CRC. The accuracy was 0.9692 with an AUC of 0.9981. The result shows a high accuracy of the two-step feature extraction method, which includes obtaining hub genes by WGCNA and a 10-dimensional representation by variational autoencoder (VAE).